Showing results (31-40 of 275) with videos related to
Sort By:
Pageof 28
Current Opinion in Oncology|September 7, 2000
Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapyR F Little, R Yarchoan, W H WilsonJournal of the American Academy of Dermatology|June 1, 1990
Antiviral therapy against HIV infectionH Mitsuya, R Yarchoan, S Hayashi, et al.The Journal of Infectious Diseases|June 2, 1998
Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapyM F Kavlick, K Wyvill, R Yarchoan, et al.Annals of Internal Medicine|October 15, 1990
NIH conference. Antiretroviral therapy in AIDSS Broder, H Mitsuya, R Yarchoan, et al.Muscle & Nerve|October 1, 1989
Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC)R M Dubinsky, R Yarchoan, M Dalakas, et al.Blood|April 15, 1995
Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replicationA Foli, M W Saville, M W Baseler, et al.Journal of HIV Therapy|November 29, 2008
Imaging techniques for Kaposi's sarcomaD O'Mahony, Ah Gandjbakche, M Hassan, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1981
Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feedingL K Richman, A S Graeff, R Yarchoan, et al.The Journal of Experimental Medicine|April 1, 1990
Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodiesC F Perno, M W Baseler, S Broder, et al.Oncology (Williston Park, N.Y.)|June 30, 1998
The challenge of designing clinical trials for AIDS-related Kaposi's sarcomaR F Little, J M Pluda, E Feigal, et al.Pageof 28